Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Pozycja w akcjach #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Cena akcji
$1.02
Kapitalizacja rynkowa
$131.45M
Zmiana (1 dzień)
-0.62%
Zmiana (1 rok)
-37.92%
Kraj
TW
Handel Pharmosa Biopharm Inc. (6875)

Kategoria

Historia ceny akcji dla Pharmosa Biopharm Inc. (6875)
Najwyższa cena zamknięcia: $1.04 dnia 2026-08-01

Najniższa cena zamknięcia: $1.60 dnia 2022-02-01
Historia cen akcji firmy Pharmosa Biopharm Inc. od 2022 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -19.43%
2025 1.72%
2024 -40.77%
2023 55.60%
2022 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$764.47 8.17%
CH